Frontlight ResearchEarly access
Trial site
Neurological Institute of New York
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease1 trial
- Mild cognitive impairment1 trial
- Multiple sclerosis1 trial
- Myasthenia gravis1 trial
- Phase
- Phase 11 trial
- Phase 31 trial
- Status
- Active, not recruiting2 trials
- Lead sponsor
- Eisai Inc.1 trial
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1 trial
Running trials
Active, not recruiting
Active, not recruiting
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease
Site data: ClinicalTrials.govUpdated 12 Nov 2026